Form 4 for CERS CERUS CORP
Accepted 2025-03-10 00:00:00 ET · period of report 2025-03-06 · accession 0000950170-25-036676 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-03-10 | 2025-03-07 | CERS | Benjamin Richard J | Chief Medical Off | S - Sale | $1.50 | -26.1K | 734.8K | -3% | -$39.2K |
| MT | 2025-03-10 | 2025-03-06 | CERS | Benjamin Richard J | Chief Medical Off | A - Grant | $0.00 | +366.6K | 694.4K | +112% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-07 | S | D | 26,139 | $1.50 | 734,799 | D | — | — | (F4) Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.445 to $1.54 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. |
| 2 | Common | Common Stock | 2025-03-06 | A | A | 66,565 | $0.00 | 760,938 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-06 | A | A | 300,000 | $0.00 | 694,373 | D | — | — |